| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Value of multiplex PCR using cerebrospinal fluid for the diagnosis of ventriculostomy-related meningitis in neurosurgery patients.
|
Infection
|
2014
|
2.09
|
|
2
|
Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma.
|
J Natl Cancer Inst
|
1996
|
1.79
|
|
3
|
Pleiotropic changes controlled by the pre-T-cell receptor.
|
Curr Opin Immunol
|
1999
|
1.71
|
|
4
|
Telomere shortening impairs organ regeneration by inhibiting cell cycle re-entry of a subpopulation of cells.
|
EMBO J
|
2003
|
1.64
|
|
5
|
CXCR4/CXCL12 expression and signalling in kidney cancer.
|
Br J Cancer
|
2002
|
1.59
|
|
6
|
Essential role of the pre-T cell receptor in allelic exclusion of the T cell receptor beta locus.
|
Immunity
|
1997
|
1.44
|
|
7
|
Pancreatic NOD beta cells express MHC class II protein and the frequency of I-A(g7) mRNA-expressing beta cells strongly increases during progression to autoimmune diabetes.
|
Diabetologia
|
2003
|
1.41
|
|
8
|
Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea.
|
Br J Pharmacol
|
2013
|
1.33
|
|
9
|
Outbreak due to a Klebsiella pneumoniae strain harbouring KPC-2 and VIM-1 in a German university hospital, July 2010 to January 2011.
|
Euro Surveill
|
2011
|
1.30
|
|
10
|
Mitogen stimulation cooperates with telomere shortening to activate DNA damage responses and senescence signaling.
|
Mol Cell Biol
|
2004
|
1.25
|
|
11
|
GARP: a key receptor controlling FOXP3 in human regulatory T cells.
|
J Cell Mol Med
|
2009
|
1.25
|
|
12
|
Fingerprints of anergic T cells.
|
Curr Biol
|
2001
|
1.19
|
|
13
|
Crucial function of the pre-T-cell receptor (TCR) in TCR beta selection, TCR beta allelic exclusion and alpha beta versus gamma delta lineage commitment.
|
Immunol Rev
|
1998
|
1.19
|
|
14
|
On the role of the pre-T cell receptor in alphabeta versus gammadelta T lineage commitment.
|
Immunity
|
1998
|
1.19
|
|
15
|
CD4+Foxp3+ regulatory T cell expansion induced by antigen-driven interaction with intestinal epithelial cells independent of local dendritic cells.
|
Gut
|
2008
|
1.12
|
|
16
|
The reprogrammed host: Chlamydia trachomatis-induced up-regulation of glycoprotein 130 cytokines, transcription factors, and antiapoptotic genes.
|
Arthritis Rheum
|
2001
|
1.08
|
|
17
|
CD4+ T cell mediated intestinal immunity: chronic inflammation versus immune regulation.
|
Gut
|
2005
|
1.06
|
|
18
|
Changes in function of antigen-specific lymphocytes correlating with progression towards diabetes in a transgenic model.
|
EMBO J
|
1998
|
1.05
|
|
19
|
Prognostic impact of in vivo soluble cell adhesion molecules in metastatic renal cell carcinoma.
|
Br J Cancer
|
1999
|
1.03
|
|
20
|
Gene expression patterns of epithelial cells modulated by pathogenicity factors of Yersinia enterocolitica.
|
Cell Microbiol
|
2004
|
1.03
|
|
21
|
In vitro-generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact allergy and systemic autoimmunity.
|
Gene Ther
|
2005
|
1.02
|
|
22
|
Biochemotherapy of advanced metastatic renal-cell carcinoma: results of the combination of interleukin-2, alpha-interferon, 5-fluorouracil, vinblastine, and 13-cis-retinoic acid.
|
World J Urol
|
1995
|
1.01
|
|
23
|
Autoimmunity resulting from cytokine treatment predicts long-term survival in patients with metastatic renal cell cancer.
|
J Clin Oncol
|
1999
|
1.00
|
|
24
|
First reported case of azole-resistant aspergillus fumigatus due to the TR/L98H mutation in Germany.
|
Antimicrob Agents Chemother
|
2012
|
0.99
|
|
25
|
Interleukin 10 (IL-10): an immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinoma.
|
Br J Cancer
|
1999
|
0.97
|
|
26
|
Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanoma.
|
Br J Cancer
|
1998
|
0.95
|
|
27
|
Immunocytochemical detection of P-glycoprotein: initial expression correlates with survival in renal cell carcinoma patients.
|
Oncology
|
1994
|
0.94
|
|
28
|
Conformational polymorphisms of cRNA of T-cell-receptor genes as a clone-specific molecular marker for cutaneous lymphoma.
|
J Invest Dermatol
|
1993
|
0.94
|
|
29
|
Infection of human endothelial cells with Staphylococcus aureus induces transcription of genes encoding an innate immunity response.
|
Scand J Immunol
|
2005
|
0.93
|
|
30
|
Vancomycin MIC creep in MRSA blood culture isolates from Germany: a regional problem?
|
Eur J Clin Microbiol Infect Dis
|
2011
|
0.91
|
|
31
|
Monitoring gene expression of TNFR family members by beta-cells during development of autoimmune diabetes.
|
Eur J Immunol
|
2000
|
0.90
|
|
32
|
Results and relevance of molecular detection of pathogens by SeptiFast--a retrospective analysis in 75 critically ill children.
|
Klin Padiatr
|
2012
|
0.90
|
|
33
|
Bilateral Bartonella henselae neuroretinitis with stellate maculopathy in a 6-year-old boy.
|
Infection
|
2011
|
0.90
|
|
34
|
Invasive aspergillosis in two liver transplant recipients: diagnosis by SeptiFast.
|
Transpl Infect Dis
|
2009
|
0.88
|
|
35
|
Inflammation in vivo is modulated by GPR83 isoform-4 but not GPR83 isoform-1 expression in regulatory T cells.
|
Genes Immun
|
2010
|
0.87
|
|
36
|
Capecitabine in the treatment of metastatic renal cell carcinoma.
|
Br J Cancer
|
2000
|
0.87
|
|
37
|
FOXP3: required but not sufficient. the role of GARP (LRRC32) as a safeguard of the regulatory phenotype.
|
Curr Mol Med
|
2010
|
0.85
|
|
38
|
Risk and outcome in metastatic malignant melanoma patients receiving DTIC, cisplatin, BCNU and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha2a.
|
Br J Cancer
|
1998
|
0.83
|
|
39
|
Bacterial colonization of chronic leg ulcers: current results compared with data 5 years ago in a specialized dermatology department.
|
J Eur Acad Dermatol Venereol
|
2010
|
0.81
|
|
40
|
Detection of small sequence differences using competitive PCR: molecular monitoring of genetically improved, mercury-reducing bacteria.
|
Biotechniques
|
2001
|
0.81
|
|
41
|
Detection of melanoma cells in peripheral blood stem cell harvests of patients with progressive metastatic malignant melanoma.
|
Br J Haematol
|
1997
|
0.81
|
|
42
|
Discrimination of Scedosporium prolificans against Pseudallescheria boydii and Scedosporium apiospermum by semiautomated repetitive sequence-based PCR.
|
Med Mycol
|
2010
|
0.80
|
|
43
|
In vitro activity of colistin as single agent and in combination with antifungals against filamentous fungi occurring in patients with cystic fibrosis.
|
Mycoses
|
2012
|
0.80
|
|
44
|
Stenotrophomonas maltophilia in cystic fibrosis: improved detection by the use of selective agar and evaluation of antimicrobial resistance.
|
J Cyst Fibros
|
2011
|
0.80
|
|
45
|
Pharmacokinetics of recombinant human interleukin-2 in advanced renal cell carcinoma patients following subcutaneous application.
|
Br J Clin Pharmacol
|
1998
|
0.79
|
|
46
|
Molecular and prognostic classification of advanced melanoma: a multi-marker microcontamination assay of peripheral blood stem cells.
|
Melanoma Res
|
2000
|
0.79
|
|
47
|
Response to 13-cis-retinoic acid plus interferon alfa-2a in two patients with therapy-refractory advanced renal cell carcinoma.
|
J Clin Oncol
|
1995
|
0.79
|
|
48
|
Detection of clonal T-cell populations in gastrointestinal lymphomas by analysis of cRNA conformational polymorphisms of rearranged T-cell-receptor-gamma genes.
|
Br J Haematol
|
1994
|
0.78
|
|
49
|
Molecular detection and characterization of clonal cell populations in acute lymphocytic leukemia by analysis of conformational polymorphisms of cRNA molecules of rearranged T-cell-receptor-gamma and immunoglobulin heavy-chain genes.
|
Leukemia
|
1994
|
0.78
|
|
50
|
Development of a quantitative immunofluorescence assay for detection of Stenotrophomonas maltophilia antibodies in patients with cystic fibrosis.
|
J Cyst Fibros
|
2013
|
0.77
|
|
51
|
Quantitative determination of the composition of multi-shell calcium phosphate-oligonucleotide nanoparticles and their application for the activation of dendritic cells.
|
Acta Biomater
|
2011
|
0.77
|
|
52
|
HLA phenotype and cytokine-induced tumor control in advanced renal cell cancer.
|
Cancer Biother Radiopharm
|
2001
|
0.77
|
|
53
|
In vivo time and dose dependency of interleukin-6 secretion in response to low-dose subcutaneous recombinant interleukin-2.
|
Cancer Biother
|
1994
|
0.76
|
|
54
|
In vivo tumor necrosis factor-alpha as indicator of biologic and clinical response to low-dose SC recombinant interleukin 2.
|
Anticancer Res
|
1995
|
0.76
|
|
55
|
[Hemicolectomy for ischemic colitis : A case report of a (H1N1) virus-associated death].
|
Chirurg
|
2010
|
0.76
|
|
56
|
Regulatory T-cells in the control of immunological diseases.
|
Ann Hematol
|
2006
|
0.76
|
|
57
|
[Chemoimmunotherapy in the systemic treatment of advanced renal carcinoma].
|
Urologe A
|
1999
|
0.76
|
|
58
|
Exposure to vinblastine modulates beta 1 integrin expression and in vitro binding to extracellular matrix molecules in a human renal carcinoma cell line.
|
Invasion Metastasis
|
1996
|
0.75
|
|
59
|
Molecular diagnosis of neoplasms.
|
N Engl J Med
|
1995
|
0.75
|
|
60
|
Caspofungin: cross-reactivity in the Aspergillus antigen assay.
|
J Clin Microbiol
|
2010
|
0.75
|
|
61
|
In vitro induced CD8+ regulatory T cells inhibit skin inflammation.
|
Eur J Microbiol Immunol (Bp)
|
2011
|
0.75
|
|
62
|
MHC class II expression by beta cells in Type 1 diabetes: promoting or inhibiting the autoimmune process? A reply to D. W. R. Gray.
|
Diabetologia
|
2004
|
0.75
|
|
63
|
Genetic abnormalities during transition from Helicobacter-pylori-associated gastritis to low-grade MALToma.
|
Lancet
|
1995
|
0.75
|
|
64
|
Linomide and interleukin-2 in patients with advanced renal cell carcinoma.
|
Cancer Biother Radiopharm
|
1996
|
0.75
|
|
65
|
Tumour microdissemination and survival in metastatic melanoma.
|
Anticancer Res
|
2000
|
0.75
|
|
66
|
Cytogenetic studies in renal cell carcinoma patients receiving low-dose recombinant interleukin-2-based immunotherapy.
|
Tumour Biol
|
1996
|
0.75
|
|
67
|
[Managing EHEC in hospital routine].
|
Dtsch Med Wochenschr
|
2012
|
0.75
|
|
68
|
[Application monitoring of the use of sorafenib in papillary renal cell carcinoma].
|
Urologe A
|
2007
|
0.75
|
|
69
|
RAR-beta(1) overexpression in chromophobe renal cell carcinoma: a novel target for therapeutic intervention?
|
Exp Oncol
|
2005
|
0.75
|